Floatz logo

b7-h3 car t cells

Germ Cell Cancer

St. Jude Children's Research HospitalCell therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

24 Active assets in the Germ Cell Cancer cohort.

Asset / SponsorPhaseRating
Carboplatin
Children's Oncology Group
Phase 3BB
ETOPOSIDE
Children's Oncology Group
Phase 3BB
Eloxatin
National Cancer Institute (NCI)
Phase 2BB
FILGRASTIM
Children's Oncology Group
Phase 2B
CIS-DIAMMINEDICHLOROPLATINUM II
Children's Oncology Group
Phase 3B

View all 35 →

Same molecule, other indications

b7-h3 car t cells is also rated in:

Pediatric Solid TumorDormant
CC
Indicative ·
43 / 100
View asset →
Wilms tumorDormant
CC
Indicative ·
43 / 100
View asset →
adrenal cortex carcinomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →